IS6400A - Kristallað form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýlfenýl}etoxý)fenýl]própanónsýra - Google Patents

Kristallað form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýlfenýl}etoxý)fenýl]própanónsýra

Info

Publication number
IS6400A
IS6400A IS6400A IS6400A IS6400A IS 6400 A IS6400 A IS 6400A IS 6400 A IS6400 A IS 6400A IS 6400 A IS6400 A IS 6400A IS 6400 A IS6400 A IS 6400A
Authority
IS
Iceland
Prior art keywords
ethoxy
methanesulfonylphenyl
phenyl
crystalline form
propanoic acid
Prior art date
Application number
IS6400A
Other languages
English (en)
Inventor
Boije Maria
Horvath Karol
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904416A external-priority patent/SE9904416D0/xx
Priority claimed from SE0001187A external-priority patent/SE0001187D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6400A publication Critical patent/IS6400A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IS6400A 1999-12-03 2002-05-28 Kristallað form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýlfenýl}etoxý)fenýl]própanónsýra IS6400A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904416A SE9904416D0 (sv) 1999-12-03 1999-12-03 Crystalline form
SE0001187A SE0001187D0 (sv) 2000-04-03 2000-04-03 Crystalline form
PCT/SE2000/002384 WO2001040171A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid

Publications (1)

Publication Number Publication Date
IS6400A true IS6400A (is) 2002-05-28

Family

ID=26655058

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6400A IS6400A (is) 1999-12-03 2002-05-28 Kristallað form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýlfenýl}etoxý)fenýl]própanónsýra

Country Status (29)

Country Link
US (1) US6531622B1 (is)
EP (1) EP1237855B1 (is)
JP (1) JP2003515582A (is)
KR (1) KR20030029040A (is)
CN (1) CN1198799C (is)
AR (1) AR029412A1 (is)
AT (1) ATE261431T1 (is)
AU (1) AU773777B2 (is)
BR (1) BR0016131A (is)
CA (1) CA2392038A1 (is)
CO (1) CO5271735A1 (is)
CZ (1) CZ20021902A3 (is)
DE (1) DE60008921T2 (is)
DK (1) DK1237855T3 (is)
EE (1) EE200200278A (is)
ES (1) ES2215769T3 (is)
HU (1) HUP0203444A3 (is)
IL (1) IL149577A0 (is)
IS (1) IS6400A (is)
MX (1) MXPA02005327A (is)
MY (1) MY135954A (is)
NO (1) NO20022598L (is)
NZ (1) NZ518925A (is)
PL (1) PL357118A1 (is)
PT (1) PT1237855E (is)
RU (1) RU2268880C2 (is)
SK (1) SK7652002A3 (is)
TR (1) TR200401333T4 (is)
WO (1) WO2001040171A1 (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
BR9812770A (pt) 1997-10-27 2000-12-12 Reddy Research Foundation Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
MXPA00004036A (es) 1997-10-27 2006-05-24 Reddys Lab Ltd Dr Compuestos triciclicos novedosos y su uso en medicina; proceso para su preparacion y composiciones farmaceuticas que los contienen..
CN1280574A (zh) 1997-10-27 2001-01-17 雷迪研究基金会 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
JP2002528535A (ja) 1998-10-29 2002-09-03 ドクター・レディーズ・リサーチ・ファウンデーション 新規抗糖尿病剤製造の改良方法
US7084177B2 (en) * 1999-12-03 2006-08-01 Astrazeneca Ab Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102004035034A1 (de) * 2004-07-20 2006-02-16 Degussa Ag Racematspaltung von p-Hydroxyphenyl-2-alkoxy-propionsäuren
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
HK1048980A1 (en) 2003-04-25
SK7652002A3 (en) 2002-11-06
HUP0203444A3 (en) 2003-05-28
EE200200278A (et) 2003-06-16
ATE261431T1 (de) 2004-03-15
CA2392038A1 (en) 2001-06-07
TR200401333T4 (tr) 2004-08-23
DE60008921T2 (de) 2005-01-20
US6531622B1 (en) 2003-03-11
EP1237855A1 (en) 2002-09-11
ES2215769T3 (es) 2004-10-16
CO5271735A1 (es) 2003-04-30
NZ518925A (en) 2004-06-25
DK1237855T3 (da) 2004-06-14
RU2002113450A (ru) 2004-01-10
PL357118A1 (en) 2004-07-12
AU773777B2 (en) 2004-06-03
CN1198799C (zh) 2005-04-27
WO2001040171A1 (en) 2001-06-07
NO20022598D0 (no) 2002-05-31
JP2003515582A (ja) 2003-05-07
NO20022598L (no) 2002-05-31
EP1237855B1 (en) 2004-03-10
CN1409701A (zh) 2003-04-09
RU2268880C2 (ru) 2006-01-27
KR20030029040A (ko) 2003-04-11
MXPA02005327A (es) 2002-12-06
MY135954A (en) 2008-07-31
CZ20021902A3 (cs) 2002-11-13
AR029412A1 (es) 2003-06-25
PT1237855E (pt) 2004-06-30
DE60008921D1 (en) 2004-04-15
AU2035001A (en) 2001-06-12
HUP0203444A2 (hu) 2003-02-28
IL149577A0 (en) 2002-11-10
BR0016131A (pt) 2002-08-20

Similar Documents

Publication Publication Date Title
IS6400A (is) Kristallað form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýlfenýl}etoxý)fenýl]própanónsýra
IS6399A (is) Mulið form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýloxýfenýl}etoxý)fenýl]própanónsýra
AU3957800A (en) Crystalline r- guanidines, arginine or (l) -arginine (2(s)) -2- ethoxy -3-(4- (2-(10(h) -phenoxazin -10-yl)ethoxy}phenyl)propanoate
LU92025I2 (fr) Méthanesulfonate d'éthylester d'acide 3-¬(2-{¬4-(hexyloxy-carbonylamino-imino-méthyl)-phénylamino-méthyl}-1-méthyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino-propionique
EE200000720A (et) Uus 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
FI20002767L (fi) Jodoniumsuolat latentteina happodonoreina
PT1100769E (pt) Derivado do acido aminometilcarboxilico
EE200000717A (et) Uus 3-arüül-2-hüdroksüpropaanhappe derivaat III
PT1077957E (pt) Derivados do acido oxi-iminoalcanoico
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
ATE237601T1 (de) Herbizide phenoxypropionsäure-n-alkyl-n-2- fluorophenylamid-verbindungen
IS2019B (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
EE200100708A (et) Asendatud fenoksüäädikhapped
IL139373A0 (en) Phenyl methoxyimino acetic acid derivatives as pesticides
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
DE60012713D1 (de) Durch xanthurensäure modifizierte proteine
ATE339438T1 (de) Substanziell kristalline form von melagatran
ID26146A (id) Proses untuk cis-1-{2-[4-(6-metoksi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il]fenoksi]etil} pirolidin
AU2034701A (en) Comminuted form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic
NO20035236D0 (no) Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3 (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl) - (S) -2-
SI1237855T1 (en) Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl) propanoic acid
IS7057A (is) Lyfjablanda sem annaðhvort felur í sér (S)-2-etoxý-3-[4-(2-{4-metansúlfónýloxýfenýl} etoxý)fenýl] própansýru eða 3-{4-[2-(4-tert-bútoxýkarbónýlamínófenýl)etoxý]fenýl}-(S)-2-etoxýprópansýru og súlónýlþvagefni
ATE348807T1 (de) Schwefelsäure mono-(3- (ä1-(2-(4-fluoro-phenyl)- ethyl)-piperidin-4-ylü -hydroxy-methyl)-2-methoxy-phenyl)ester
SE9801991D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative II